PC

Paul Conley

Founder of General Inception

Palo Alto, California

Overview 

Paul Conley is a seasoned professional with a strong track record in deep-tech company formation and venture capital, currently serving as the Founder/CEO of General Inception and as a Venture Partner at Vertical Venture Partners. Notable highlights of his career include his role as Managing Director for Venture Studio Operations at Paladin Capital Group and his involvement as an investor and board member in companies like 10X Genomics and Menlo Micro.

Work Experience 

  • CEO & Co-founder

    2020 - Current

    A venture igniter company dedicated to technical founders who need ignition capital ($50k - 1.5M), hands-on technology development and access to customers on the way to preparing for their first financing round.

General Inception is an institutional co-founder for science-based companies.

  • Venture Partner

    2015

    Early stage investor in B2B start-ups who are solving vertical industry problems that are not addressed by general purpose products. VVP invests at the intersection of new technologies and industry specific solutions, including (but not limited to) healthcare, education, insurance, aero/defense, retail, travel, real-estate, transportation, energy, etc.

  • Managing Director for Venture Studio Operations

    2007

    Paladin is a multi-stage private equity firm with a concentration on expansion and growth stage investments in companies whose products or services address the security and resilience of US critical infrastructure.

  • Board Member

    2022

  • fmr Board Member (NASDAQ: TXG)

    2012

  • fmr Board Member (NASDAQ: TWST)

    2013

Twist Bioscience is a biotechnology company that offers synthetic DNA solutions, gene synthesis, and variant libraries.

Raised $553,110,714.00 from Capital World Investors.

  • Board Observer

    2024

  • Board Member

    2023

Partillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform.

Raised $6,067,053.00 from +ND Capital, Vertical Venture Partners and Paladin Capital Group.

  • Board Member

    2021

Alida Biosciences is a biotech company creating RNA analysis tools to improve human health.

Raised $16,610,000.00 from National Human Genome Research Institute.

Education 

Articles About Paul

Relevant Websites